Oncobox YC 申请
Oncobox 在 Summer 2017 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。
- YC 批次
- Summer 2017
- 行业
- HealthcareDiagnostics
- 团队规模
- 11
- 状态
- Active
- 已发布
- 2017
创始人
Andrew GarazhaFounder/CEO
Anton BuzdinFounder/CSO
Oncobox 做什么
Oncobox believes that many late-stage cancer patients are dying prematurely because doctors lack a data-driven tool to help them decide which drugs currently on the market would most effectively fight individual patients’ specific cancers. That’s where Oncobox comes in. Oncobox is low-cost personalized genetic profiling to help doctors decide which drug to use. In a recent study conducted by leading cancer researchers in Europe and Asia on 900 patients with various late-stage cancers, Oncobox increased the effectiveness of targeted therapies from 25% to 64%. How does Oncobox work? Over 150 targeted cancer drugs are currently on the market. But deciding which of these drugs to give to late-stage cancer patients is not a simple task. Cancer doctors are in a race against the clock. They don’t always know which medication will be most effective for their patients. Because these drugs are expensive and typically have significant side effects, they can’t just try them all. Because of these barriers, targeted cancer therapies are effective only 25% of the time, and 70% of patients with late-stage cancers die due to the toxic side effects of ineffective drugs. Oncobox Dx analyses tumor DNA, RNA, and molecular pathways using algorithms to distinguish which molecular targets are the most crucial for individual cases. Doctors receive a clinically actionable report that shows them which drugs are likely to be most effective on the patient. We actively seek partners from pharma, hospitals/clinicians, payers, and genomic centers. Feel free to contact us at. Our team and the scientific advisory board consisting of leading scientists and researchers from UCLA, Stanford, Johns Hopkins University, Boston University, Tufts University, and Rutgers University.
Oncobox 的 YC 申请，重建版
Y Combinator 申请
Oncobox，Summer 2017 期。来自公开数据的真实申请问题解答。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Oncobox
Finding the right cancer drug for each patient.
Oncobox analyzes tumor DNA, RNA, and molecular pathways to produce a report that helps oncologists pick the most effective targeted cancer drugs for an individual patient. Our product focuses on late-stage cancer patients, where current targeted therapies only work 25% of the time. Our system increases that effectiveness significantly by identifying the key molecular targets specific to each tumor.
We live in Walnut, CA and would base the company here after YC.
We are already based in Walnut, CA and want to stay here because of access to regional research partners and proximity to biotech clusters in California.
21 更多回答 在完整申请中
Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。
常见问题解答
这是 Oncobox 的真实 YC 申请吗？
不是。Y Combinator 对提交的申请保密。这是重建版：使用 Oncobox 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Oncobox 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。
Oncobox 是哪个 YC 批次的？
Oncobox 是 Y Combinator Summer 2017 批次的成员。
谁创立了 Oncobox？
Oncobox 由 Andrew Garazha, Anton Buzdin 创立。
Oncobox 做什么？
Finding the right cancer drug for each patient.
如何阅读完整的重建申请？
创建免费的 Round Funded 账户。YC Insights 中包含 Oncobox 的完整 26 个问题的版本，以及其他所有 YC 批次的公司信息。
更多 YC 初创公司，例如 Oncobox
